Eli Svaty is the executive director of the Seward County Development Corporation and recent president of the Western Kansas ...
A young man (Dylan Flashner) embraces the murderous urges that landed his father (Dermot Mulroney) on death row.
Barry Jay discusses 'Like Father Like Son,' why the film is a landmark moment for him, and his decision to hang up his director's hat.
"The Righteous Gemstones," a comedy-drama series created by and starring Danny McBride, will return for a fourth and final ...
Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...
However, there are other multiple notable characters set to appear in this flick. so let’s talk about the star-studded cast of Captain America: Brave New World! Anthony Mackie’s journey as the Falcon ...
The FDA ap­proved Eli Lil­ly’s Omvoh in Crohn’s dis­ease, the com­pa­ny an­nounced Wednes­day, hand­ing the drug its sec­ond in­di­ca­tion af­ter giv­ing it a green light … ...
Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...
What will Eli Lilly do with all its cash from Mounjaro and Zepbound? What does CEO Dave Ricks think it would take for the company to reach a $1 trillion market capitalization? And how does Ricks ...
SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...
Eli Lilly (NYSE: LLY) saw its stock decline sharply by 6.5% on January 14, following the release of its fourth-quarter 2024 revenue guidance, which fell short of Wall Street expectations. The ...
Lilly plans to share its full Q4 2024 results on 6 February 2025. Credit: JHVEPhoto via Getty Images. Eli Lilly has announced a $400m reduction in its 2024 revenue forecast, marking a 3% shortfall ...